Yew Bio-Pharm Group (OTCMKTS:YEWB) and Alico (NASDAQ:ALCO) are both small-cap consumer staples companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership and profitability.
This table compares Yew Bio-Pharm Group and Alico’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Yew Bio-Pharm Group||-15.61%||-11.43%||-9.88%|
Earnings & Valuation
This table compares Yew Bio-Pharm Group and Alico’s gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Yew Bio-Pharm Group||$40.54 million||0.31||$3.21 million||N/A||N/A|
|Alico||$129.83 million||2.09||-$9.45 million||N/A||N/A|
Yew Bio-Pharm Group has higher earnings, but lower revenue than Alico.
Alico pays an annual dividend of $0.24 per share and has a dividend yield of 0.7%. Yew Bio-Pharm Group does not pay a dividend.
Insider & Institutional Ownership
74.7% of Alico shares are owned by institutional investors. 63.7% of Yew Bio-Pharm Group shares are owned by company insiders. Comparatively, 60.1% of Alico shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
This is a summary of current ratings and recommmendations for Yew Bio-Pharm Group and Alico, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Yew Bio-Pharm Group||0||0||0||0||N/A|
Risk & Volatility
Yew Bio-Pharm Group has a beta of 0.95, meaning that its share price is 5% less volatile than the S&P 500. Comparatively, Alico has a beta of 0.64, meaning that its share price is 36% less volatile than the S&P 500.
Alico beats Yew Bio-Pharm Group on 7 of the 10 factors compared between the two stocks.
About Yew Bio-Pharm Group
Yew Bio-Pharm Group, Inc., through its subsidiaries, grows and sells yew trees in the People's Republic of China. It operates through four segments: Traditional Chinese Medicine (TCM) Raw Materials, Yew Trees, Handicrafts, and Others. The TCM Raw Materials segment engages in the production and sale of raw materials that are used in the manufacture of TCM. It offers yew raw materials, including branches and leaves of yew trees. The Yew Tree segment is involved in growing and selling yew seedlings and mature trees. It cultivates and sells yew seedlings and trees to state-owned enterprises and private businesses for reforestation in the provinces of Heilongjiang and Jilin; and sells potted yew trees to retail customers. The Handicrafts segment manufactures and sells furniture and handicrafts made of yew timber. The Others segment sells yew candles, pine needle extracts, complex taxus cuspidate extract, composite northeast yew extract, and yew essential oil soap. The company also sells wood ear mushroom. Yew Bio-Pharm Group, Inc. was incorporated in 2007 and is based in El Monte, California.
Alico, Inc., together with its subsidiaries, operates as an agribusiness and land management company in the United States. The company operates through three segments: Alico Citrus, Conservation and Environmental Resources, and Other Operations. The Alico Citrus segment engages in planting, owning, cultivating, and/or managing citrus groves to produce fruits for sale to fresh and processed citrus markets; and contracting for the harvesting, marketing, and hauling of citrus. The Conservation and Environmental Resources segment is involved in the activities related to cattle grazing, sod, native plant, and animal sales; and leasing, management, and/or conservation of unimproved native pasture land. The Other Operations segment engages in the activities related to rock mining royalties, oil exploration, and other lines of business; and ownership and/or lease of improved farmland. Alico, Inc. owned approximately 122,000 acres of land located in 12 counties in Florida, which include the Alachua, Charlotte, Collier, DeSoto, Glades, Hardee, Hendry, Highlands, Lee, Martin, Osceola, and Polk. The company was founded in 1960 and is based in Fort Myers, Florida. Alico, Inc. is a subsidiary of 734 Investors, LLC.
Receive News & Ratings for Yew Bio-Pharm Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yew Bio-Pharm Group and related companies with MarketBeat.com's FREE daily email newsletter.